五月 2026
xtandi.com
显示 Similarweb 估计数据。
关联 GA4,公开验证您的网站指标
与您的成功同步
绑定 Google Analytics,验证您网站的流量及用户参与度指标
跳出率
69.15%
每次访问页数
1.53
平均访问时长
00:01:02
- 公司
- - -
- 行业
- - -
xtandi.com的 10 大竞争对手
在 五月 2026 与 xtandi.com 相似的前 10 名网站,按关键字流量、受众定位和市场重叠方面与 xtandi.com 的关联性排名
Learn how TRODELVY® (sacituzumab govitecan‐hziy) is thought to work in adult patients with pretreated HR+/HER2- metastatic breast cancer. TRODELVY is an antibody‐drug. For adult patients. See Important Facts & Important Warning.
- 公司
- - -
- 行业
- - -
跳出率
71.05%
每次访问页数
1.48
平均访问时长
00:00:57
相似度评分
100%The requested page could not be found for IBRANCE® (palbociclib). See safety info.
- 公司
- - -
- 行业
- - -
跳出率
72.89%
每次访问页数
1.48
平均访问时长
00:00:12
相似度评分
98%Find valuable information about ENHERTU® (fam-trastuzumab deruxtecan-nxki), including clinical trial results, safety information, downloadable resources, and more. See the full Important Safety Information, Prescribing Information, including Boxed WARNINGS, and Medication Guide for more information.
- 公司
- - -
- 行业
- - -
跳出率
74.33%
每次访问页数
1.48
平均访问时长
00:00:51
相似度评分
95%learn about keytruda® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers. visit the patient website.
- 公司
- - -
- 行业
- - -
跳出率
73.82%
每次访问页数
1.40
平均访问时长
00:00:32
See risks and benefits. Visit the official Lorbrena® (lorlatinib) patient site to learn about clinical trial results.
- 公司
- - -
- 行业
- - -
跳出率
57.3%
每次访问页数
2.86
平均访问时长
00:02:43
Please see Important Safety Information and full Prescribing Information.
- 公司
- - -
- 行业
- - -
跳出率
72.79%
每次访问页数
1.27
平均访问时长
00:00:37
Ontada®, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, was awarded a competitive contract with the U.S. Food and Drug Administration (FDA) to advance the use of real-world data (RWD) in the U.S. community oncology setting. The research aims to strengthen the scientific understanding of the natural history of rare cancers by leveraging Ontada’s community oncology footprint, unique RWD, and experience in real-world research (RWR).
跳出率
27.08%
每次访问页数
2.96
平均访问时长
00:02:28
相似度评分
86%Learn about BRUKINSA® (zanubrutinib), a BTK inhibitor for Chronic Lymphocytic Leukemia (CLL). See Important Safety Information and Prescribing Information.
- 公司
- - -
- 行业
- - -
跳出率
75.05%
每次访问页数
1.31
平均访问时长
00:01:49
Access and download helpful patient support materials and links to breast cancer support groups. See Full Safety, including most serious side effects, for more information.
- 公司
- - -
- 行业
- - -
跳出率
79.91%
每次访问页数
1.17
平均访问时长
00:00:06
相似度评分
84%We're striving for a world where no man dies of prostate cancer - and giving every man the power to navigate this complex disease. We're standing together to support our dads, brothers, partners and friends - by raising awareness, funding lifesaving research, campaigning for change and providing helpful support and information.
跳出率
53.37%
每次访问页数
2.09
平均访问时长
00:01:26
xtandi.com在 五月 2026 的前五名竞争对手是:trodelvy.com、ibrance.com、enhertu.com、keytruda.com等。
根据 Similarweb 的月访问量数据,xtandi.com 在 五月 2026 的头号竞争对手是 trodelvy.com。与 xtandi.com 相似度排名第二的网站是 ibrance.com,排名第三的是 enhertu.com。
在 五月 2026,keytruda.com 被评为与 xtandi.com 相似度第四高的网站,lorbrena.com 位居第五。
进入前十名榜单的其他五家竞争对手分别是 alunbrig.com、ontada.com、brukinsa.com、phesgo.com 和 prostatecanceruk.org。
